Antiviral resistance of HPAI-H5N1 virus isolated from poultry in Sulawesi, 2017-2018
No Thumbnail Available
Date
2021-07
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Avian Influenza (AI) is an infectious disease caused by the influenza type A virus. The highly
pathogenic AI (HPAI) H5N1 outbreak in Indonesia has occurred since 2003 until now.
Education, biosecurity, vaccination, elimination, diagnostic, and surveillance are strategy to
prevent and control AI virus (AIV) infection. Providing antiviral drug can be used as an
alternative to control AIV in poultry, but it will be limited if resistance occurs. This study aims
to determine the resistance to neuraminidase inhibitors (NAIs) (oseltamivir) and M2 ion channel
inhibitors (amantadine) of HPAI H5N1 virus isolated from poultry in Sulawesi during 2017-
2018. This research was conducted by whole-genome sequencing (WGS) with the next
generation sequencing (NGS) (Illumina) technique on 5 poultry virus isolates. Molecular analysis
was performed by multiple alignments and amino acid prediction using the MEGA X program.
Antiviral resistance of oseltamivir and amantadine was assessed based on analysis of NA and
M2 proteins compared to reference isolates from Sulawesi in NCBI. Based on the NA protein
analysis, no mutations were found at positions 119, 275, 293, and 295, indicating that all the
samples and reference isolates from Sulawesi are still sensitive to oseltamivir. Whereas at
positions 26, 27, 30, 31, and 34 of M2 protein, there was a V27I mutation in Sulawesi reference
isolate in 2016 and the combination of V27A and S31N mutations in 2 research isolates in 2018,
which indicate possible resistance to amantadine. In conclusion, there is amantadine resistance
of HPAI-H5N1 virus isolated from poultry in Sulawesi, 2018
Description
Keywords
Resistance, antivirals, oseltamivir, amantadine, HPAI H5N1, poultry